A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy by Kiyotani Kazuma, Uno Satoko, Mushiroda Taisei, Takahashi Atsushi, Kubo Michiaki, Mitsuhata Naoki, Ina Shinomi, Kihara Chikashi, Kimura Yasutoshi, Yamaue Hiroki, Hirata Koichi, Nakamura Yusuke, Zembutsu Hitoshi in Pharmacogenetics and genomics (2012).

[PMID: 22293537] PubMed

Abstract

Discussed In Paper

Loading...

Variant Annotations

Sign in to see variant annotations.

Dosing Information

No dosing information annotated.